Randomized Trial to Evaluate the Effectiveness of X-22 as a Smoking Cessation Aid

PHASE2CompletedINTERVENTIONAL
Enrollment

234

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Smoking Cessation
Interventions
DRUG

X-22 Smoking Cessation Product

"The X-22 Smoking Cessation Product is a tobacco-based (botanical) medical product consisting of very low nicotine (VLN) cigarettes.~Subjects will be allowed to smoke as much as desired throughout the 6-week treatment period."

DRUG

Active Control Cigarettes

"The Active Control cigarette is identical to the X-22 cigarette except for the tobacco, which has a nicotine content similar to that of a conventional light cigarette.~Subjects will be allowed to smoke as much as desired throughout the 6-week treatment period."

Trial Locations (3)

70006

Benchmark Research New Orleans, Metairie

78705

Benchmark Research Austin, Austin

95816

Benchmark Research Sacramento, Sacramento

All Listed Sponsors
lead

22nd Century Limited, LLC

INDUSTRY

NCT01400815 - Randomized Trial to Evaluate the Effectiveness of X-22 as a Smoking Cessation Aid | Biotech Hunter | Biotech Hunter